Paclitaxel protein-bound particles for injectable suspension (albumin-bound)
- Product NDC
- 60505-6230
- 11-digit product format
- 605056230
- Labeler code
- 60505
- Product ID
- 60505-6230_7325d86b-947f-41a1-bf26-7e988fd17b2e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Paclitaxel
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- INTRAVENOUS
- Labeler
- Apotex Corp.
- Application
- NDA021660
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2022-04-01
- Marketing end
- 0000-00-00
- Substance
- PACLITAXEL
- Active strength
- 100 mg/20mL
- Pharmacologic classes
- Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60505-6230 | PACLITAXEL PROTEIN-BOUND PARTICLES FOR INJECTABLE SUSPENSION (ALBUMIN-BOUND) (PACLITAXEL) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [APOTEX CORP.] | 3 | Legacy NDC | 20250122_0ab36ac8-0536-4677-b7d0-0d5f9561f76f.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60505-6230-4 | 60505623004 | 1 VIAL, SINGLE-USE in 1 CARTON (60505-6230-4) > 20 mL in 1 VIAL, SINGLE-USE | 2022-04-01 | 0000-00-00 | No | No | Current |